C4 Therapeutics, Inc. · NASDAQ:CCCC

BCLS II Equity Opportunities, LP reported a 6.25% stake in C4 Therapeutics, Inc. (Schedule 13G)

Event Oct 17, 2025 · Filed Oct 24, 2025

BCLS II Equity Opportunities, LP reported a 6.25% stake in C4 Therapeutics, Inc., 6,060,000 shares, as a passive investor on Oct 17, 2025. Filed Oct 24, 2025 (Schedule 13G).

Stake
6.25%
Shares
6,060,000
Intent
Passive
What changed
Crossed above 5%
Filed together
3 holders

The filing in full

HolderStakeShares
Bain Capital Life Sciences Fund II, L.P.1.07%991,188
BCIP Life Sciences Associates, LP0.13%120,722
BCLS II Equity Opportunities, LP6.25%6,060,000

Source

View original at SEC

Related